Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
2025 · Journal for ImmunoTherapy of Cancer · 5 citations
https://doi.org/10.1136/jitc-2024-009352